Skip to main content
. 2022 Jul 7;9:937913. doi: 10.3389/fcvm.2022.937913

TABLE 1.

Baseline characteristics.

Characteristics Total
(n = 90)
Group A
(n = 30)
Group B
(n = 30)
Group C
(n = 30)
P-value
Age, years ± SD 62.5 ± 10.5 61 ± 10 63 ± 13 63 ± 13 0.74
Male gender, n (%) 57 (63.3) 18 (60) 19 (63.3) 20 (66.7) 0.87
Diabetes mellitus, n (%) 12 (13.3) 4 (13.3) 5 (16.7) 3 (10) 0.93
Hypertension, n (%) 44 (48.9) 11 (36.7) 18 (60) 15 (50) 0.19
Stroke/TIA (including lacunar), n (%) 16 (17.8) 4 (13.3) 9 (30) 3 (10) 0.95
Heart failure, n (%) 10 (11.1) 2 (6.7) 5 (16.7) 3 (10) 0.59
CHD, n (%) 16 (17.8) 5 (16.7) 4 (13.3) 7 (23.3) 0.59
BMI, kg/m2, mean ± SD 24.35 ± 3.66 25.17 ± 2.78 23.88 ± 4.43 24.01 ± 3.66 0.12
Smoke, n (%) 33 (36.7) 10 (33.3) 11 (36.7) 12 (40) 0.87
LA diameter (mm), mean ± SD 36.1 ± 3.8 35.9 ± 3.5 35.8 ± 4.4 36.6 ± 3.5 0.45
LVEF (%), mean ± SD 68.6 ± 7.0 67.9 ± 6.2 69.2 ± 6.7 68.6 ± 8.1 0.77
CHA2DS2-VASc, mean ± SD 2.2 ± 1.5 1.9 ± 1.4 2.1 ± 1.4 2.7 ± 1.5 0.06

BMI, body mass index; LA, left atrium; CHD, coronary heart disease; LVEF, left ventricular ejection fraction.